Will Delaat

Recent Speaker

Chairman Medicines Australia

October 28, 2009

More than just pills: Australia's pharmaceuticals industry and why we should value it

Will has over 35 years of experience in the pharmaceuticals industry, having held a variety of roles in Europe and Australia across three multinational companies.  He has been on the Board of Medicines Australia since 1997 and was previously Chairman from 2003-2005. 

During this term he co-chaired the taskforce which implemented the pharmaceutical provisions of the AUS FTA.  Following his retirement as Managing Director of Merck Sharpe & Dohme (MSD) Australia and Merck’s Regional Director for Australia and New Zealand, Will was appointed Independent Chairman of Medicines Australia in 2007.  Will is the Chair of the Pharmaceuticals Industry Council (PIC), a member of the Pharmaceuticals Industry Strategy Group (PISG) and the Pharmaceuticals Industry Working Group (PIWG), and co-Chair of the Access to Medicines Working Group (AMWG). 

In June 2008, Will was appointed as a Director the Board of Pharmaxis, a local specialist pharmaceutical company involved in developing therapeutic products for chronic respiratory and autoimmune diseases.